Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upkar S Gill

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Gut|January 15, 2018
Liver sampling: a vital window into HBV pathogenesis on the path to functional cureUpkar S Gill, Laura J Pallett, Patrick T F Kennedy, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2022
Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virusCarla Usai, Upkar S Gill, Anna C Riddell, et al.
Briefings in Bioinformatics|February 27, 2023
IBRAP: integrated benchmarking single-cell RNA-sequencing analytical pipelineConnor H Knight, Faraz Khan, Ankit Patel, et al.
JHEP Reports : Innovation in Hepatology|May 2, 2022
Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infectionTobias Boettler, Upkar S Gill, Lena Allweiss, et al.
JHEP Reports : Innovation in Hepatology|May 4, 2023
Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studiesGeorgia Zeng, Apostolos Koffas, Lung-Yi Mak, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysisGeorgia Zeng, Benjamin R Holmes, Saleh A Alqahtani, et al.
Hepatology International|February 27, 2021
Chronic hepatitis B: the demise of the 'inactive carrier' phaseApostolos Koffas, Manoj Kumar, Upkar S Gill, et al.
Frontiers in Immunology|January 31, 2022
The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19Carla Usai, Joseph M Gibbons, Corinna Pade, et al.
Communications Medicine|December 23, 2025
A genes and health recall study of intrahepatic cholestasis of pregnancy and cholestatic liver diseaseMaria Constantinides, Joseph Gafton, Ana Cristina Angel Garcia, et al.
Plos Pathogens|August 4, 2016
Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In VivoUpkar S Gill, Dimitra Peppa, Lorenzo Micco, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Gut|January 15, 2018
Liver sampling: a vital window into HBV pathogenesis on the path to functional cureUpkar S Gill, Laura J Pallett, Patrick T F Kennedy, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2022
Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virusCarla Usai, Upkar S Gill, Anna C Riddell, et al.
Briefings in Bioinformatics|February 27, 2023
IBRAP: integrated benchmarking single-cell RNA-sequencing analytical pipelineConnor H Knight, Faraz Khan, Ankit Patel, et al.
JHEP Reports : Innovation in Hepatology|May 2, 2022
Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infectionTobias Boettler, Upkar S Gill, Lena Allweiss, et al.
JHEP Reports : Innovation in Hepatology|May 4, 2023
Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studiesGeorgia Zeng, Apostolos Koffas, Lung-Yi Mak, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysisGeorgia Zeng, Benjamin R Holmes, Saleh A Alqahtani, et al.
Hepatology International|February 27, 2021
Chronic hepatitis B: the demise of the 'inactive carrier' phaseApostolos Koffas, Manoj Kumar, Upkar S Gill, et al.
Frontiers in Immunology|January 31, 2022
The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19Carla Usai, Joseph M Gibbons, Corinna Pade, et al.
Communications Medicine|December 23, 2025
A genes and health recall study of intrahepatic cholestasis of pregnancy and cholestatic liver diseaseMaria Constantinides, Joseph Gafton, Ana Cristina Angel Garcia, et al.
Plos Pathogens|August 4, 2016
Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In VivoUpkar S Gill, Dimitra Peppa, Lorenzo Micco, et al.
Pageof 6